Literature DB >> 22050112

Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature.

Damir Erkapic1, Salvatore De Rosa, Augustin Kelava, Ralf Lehmann, Stephan Fichtlscherer, Stefan H Hohnloser.   

Abstract

BACKGROUND: Permanent pacemaker (PM) requirement is a known complication after transcatheter aortic valve implantation (TAVI). There are, however, no systematic data concerning this complication.
OBJECTIVE: To determine the incidence and potential predictors of permanent PM requirement after TAVI based on published literature.
METHODS: We conducted a MEDLINE search to identify potentially relevant literature dealing with PM requirement after TAVI. Data were collected on paper extraction forms by 2 independent investigators.
RESULTS: There were 32 relevant published studies comprising data of 5,258 patients without an implanted PM before TAVI. An Edwards-Sapiens® prosthesis (ESP) was implanted in 2,887 patients, whereas 2,371 patients received a CoreValve® prosthesis (CVP). The crude incidence of PM implantation after TAVI was 15%. Six hundred and fourteen of 2,371 (25.8%) CVP patients and 189 of the 2,887 (6.5%) ESP patients had to receive a permanent PM (odds ratio [OR] 4.91, 95% confidence interval [CI] 4.12-5.86, P < 0.001). Presence of right bundle branch block (RBBB) before TAVI was a significant predictor for development of complete atrioventricular (AV) block and subsequent PM need (OR 1.358, 95% CI 1.001-1.841, P = 0.02). More than 90% of all AV-block requiring PM implantation occurred immediately or within 7 days after TAVI.
CONCLUSION: Patients undergoing TAVI with implantation of CVP are at significantly higher risk for development of AV block and subsequent need for permanent PM, particularly if RBBB preexists. Since AV block occurs in >90% within the first week after the procedure, careful monitoring should be performed for at least 7 days after TAVI.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22050112     DOI: 10.1111/j.1540-8167.2011.02211.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  46 in total

1.  Transvascular transcatheter aortic valve implantation in 2017.

Authors:  Luise Gaede; Johannes Blumenstein; Christoph Liebetrau; Oliver Dörr; Won-Keun Kim; Holger Nef; Oliver Husser; Jan Gülker; Albrecht Elsässer; Christian W Hamm; Stephan Achenbach; Helge Möllmann
Journal:  Clin Res Cardiol       Date:  2019-06-24       Impact factor: 5.460

Review 2.  Transcatheter aortic valve replacement: an update.

Authors:  Sharif A Halim; Todd L Kiefer; G Chad Hughes; Lynne M Hurwitz; J Kevin Harrison
Journal:  Curr Cardiol Rep       Date:  2013-06       Impact factor: 2.931

3.  Conduction disorders after transcatheter aortic valve implantation: a focused review.

Authors:  Kelly M W McDonnell; Richard K Shepard
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-08

Review 4.  Clinical significance of conduction disturbances after aortic valve intervention: current evidence.

Authors:  Manuel Martinez-Selles; Peter Bramlage; Martin Thoenes; Gerhard Schymik
Journal:  Clin Res Cardiol       Date:  2014-07-04       Impact factor: 5.460

Review 5.  Future of transcatheter aortic valve implantation - evolving clinical indications.

Authors:  Rishi Puri; Chekrallah Chamandi; Tania Rodriguez-Gabella; Josep Rodés-Cabau
Journal:  Nat Rev Cardiol       Date:  2017-08-24       Impact factor: 32.419

6.  Permanent Pacemaker Implantation after TAVR - Predictors and Impact on Outcomes.

Authors:  Marcel Weber; Jan-Malte Sinning; Christoph Hammerstingl; Nikos Werner; Eberhard Grube; Georg Nickenig
Journal:  Interv Cardiol       Date:  2015-05

Review 7.  Permanent pacemaker insertion in patients with conduction abnormalities post transcatheter aortic valve replacement: a review and proposed guidelines.

Authors:  Tamunoinemi Bob-Manuel; Amit Nanda; Samuel Latham; Issa Pour-Ghaz; William Paul Skelton; Rami N Khouzam
Journal:  Ann Transl Med       Date:  2018-01

8.  Atrial Fibrillation is Associated with Increased Pacemaker Implantation Rates in the Placement of AoRTic Transcatheter Valve (PARTNER) Trial.

Authors:  Angelo B Biviano; Tamim Nazif; Jose Dizon; Hasan Garan; Mark Abrams; Jessica Fleitman; Dua Hassan; Samir Kapadia; Vasilis Babaliaros; Ke Xu; Josep Rodes-Cabau; Wilson Y Szeto; William F Fearon; Danny Dvir; Todd Dewey; Mathew Williams; Steven Kindsvater; Michael J Mack; John G Webb; D Craig Miller; Craig R Smith; Martin B Leon; Susheel Kodali
Journal:  J Atr Fibrillation       Date:  2017-06-30

9.  Transient and persistent conduction abnormalities following transcatheter aortic valve replacement with the Edwards-Sapien prosthesis: a comparison between antegrade vs. retrograde approaches.

Authors:  Solomon J Sager; Abdulla A Damluji; Joshua A Cohen; Sachil Shah; Brian P O'Neill; Carlos E Alfonso; Claudia A Martinez; Robert J Myerburg; Alan W Heldman; Mauricio G Cohen; Donald B Williams; Roger G Carrillo
Journal:  J Interv Card Electrophysiol       Date:  2016-05-28       Impact factor: 1.900

10.  Short-term pacemaker dependency after transcatheter aortic valve implantation.

Authors:  Christiana Schernthaner; Johannes Kraus; Franz Danmayr; Matthias Hammerer; Jens Schneider; Uta C Hoppe; Bernhard Strohmer
Journal:  Wien Klin Wochenschr       Date:  2016-01-08       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.